As mentioned above, down-regulation of miR-200 s predicts a poor outcome in breast cancer patients via elevated expression of Fli-1 and TGF-β, contributing to ECM remodeling and triggering breast cancer cell invasion and metastasis both in vitro and in vivo [61]. The gene discussed is FLI1; the disease is breast carcinoma.